Please login to the form below

Not currently logged in
Email:
Password:

Health Economics

This page shows the latest Health Economics news and features for those working in and with pharma, biotech and healthcare.

W2O rebrands as ‘health innovation company’ Real Chemistry

W2O rebrands as ‘health innovation company’ Real Chemistry

Real Chemistry is a ‘health innovation company’ designed to address the disruptive forces currently occurring within the healthcare space, such as digitisation, consumerism and value-based care. ... The company combines services in digital marketing,

Latest news

  • We've got this! We've got this!

    been. All of those changes, from sulphonamides to CAR-T and from regulation to health economics, hit the industry, made us feel uncomfortable and made evolution non-negotiable.

  • OPEN Health expands global footprint with Pharmerit International integration OPEN Health expands global footprint with Pharmerit International integration

    Global health comms and market access group now has presence in six countries. ... Pharmerit International is an expert in health economics and outcomes research (HEOR), and the integration of the company into the OPEN Health group establishes a new

  • New hires at Havas Life Medicom New hires at Havas Life Medicom

    She has also worked for the Office of Health Economics (part of the ABPI) helping to grow their health economics consultancy. ... Strengthening Havas Life’s editorial team is Richard Power, who joins the agency as an editorial writer, with a background

  • Report shows benefits of GP at Hand digital service, but concerns too Report shows benefits of GP at Hand digital service, but concerns too

    However the in-depth study by Ipsos MORI and York Health Economics Consortium also confirmed some existing concerns about the service’s introduction to the NHS, showing the service has attracted ... because health secretary Matt Hancock is also a vocal

  • Huntsworth bolsters market access capabilities with Creativ-Ceutical Huntsworth bolsters market access capabilities with Creativ-Ceutical

    Adds new capabilities and global presence. International health comms agency Huntsworth has bolstered its presence in health economics and market access services with the acquisition of Creativ-Ceutical.

More from news
Approximately 1 fully matching, plus 108 partially matching documents found.

Latest Intelligence

  • Achieving an agile supply chain Achieving an agile supply chain

    To achieve the rapid change and adjustment required to respond to supply chain disruption – whether that is due to economics, weather or health events – automation is essential.

  • Successful product commercialisation: what can we learn from the rare disease setting? Successful product commercialisation: what can we learn from the rare disease setting?

    Many companies are already implementing such approaches, with digital health technology at the forefront (including development of wearable devices and apps), and a focus on working in partnership with patient representatives ... Ultimately, a value

  • Growing evidence supports the important role of biosimilars in healthcare Growing evidence supports the important role of biosimilars in healthcare

    Thus, health systems experience fewer hospitalisations, less need for IV antibiotics and fewer costs associated with these interventions. ... Edward Li is Director, Health Economics and Outcomes Research at Sandoz.

  • The mission matters The mission matters

    As a global industry, we do this via about 200 countries, each of which has differing health systems, payer environments and regulatory schemes. ... economics. As Deborah Dunsire, CEO of Lundbeck, put it, our industry demands a very high concentration of

  • Gene therapy market access Q&A Gene therapy market access Q&A

    Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult. ... and the role of the Health Economics and Market Access function is to provide expertise around commercialisation and market access issues.

More from intelligence
Approximately 0 fully matching, plus 37 partially matching documents found.

Latest appointments

  • Vintura appoints Lieven Annemans as an associate partner Vintura appoints Lieven Annemans as an associate partner

    He will advise the consultancy's clients on market access issues. Healthcare and life sciences consultancy firm Vintura has appointed health-economics professor Lieven Annemans as an associate partner after previously ... Bas Amesz, partner at Vintura,

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and

  • Astellas appoints new senior VP Astellas appoints new senior VP

    Dodson has previously led the alignment of medical affairs practices, policies and standards at Astellas, and she has taken on projects such as expanding the Health Economics and Outcomes Research function,

  • McCann Health expands consulting team McCann Health expands consulting team

    Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... Prior to this, Wheatley Price was associate director of health

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 44 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics